Catalyst Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
September 22 2017 - 8:01AM
Catalyst Biosciences, Inc. (Nasdaq:CBIO) today announced that
Nassim Usman, Ph.D., President and Chief Executive Officer, will
present a corporate overview at the Ladenburg Thalmann 2017
Healthcare Conference being held in New York City. The Catalyst
Biosciences presentation will be held on Tuesday, September 26,
2017 at 3:30 p.m. Eastern Time.
About Catalyst Catalyst is a
clinical-stage biopharmaceutical company focused on developing
novel medicines to address hematology indications. Catalyst is
focused on the field of hemostasis, including the subcutaneous
prophylaxis of hemophilia and facilitating surgery in individuals
with hemophilia. For more information, please
visit www.catalystbiosciences.com.
Contacts:
Investors:
Fletcher Payne, CFO, Catalyst Biosciences
650.871.0761
investors@catbio.com
Media:
Denise Powell
510.703.9491
denise@redhousecomms.com
Catalyst Biosciences (NASDAQ:CBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catalyst Biosciences (NASDAQ:CBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024